Retatrutide, a experimental dual stimulator of the GLP-1 binding site and glucose-dependent insulinotropic polypeptide (GIP) receptor , is showing promising data in preliminary patient trials . Ongoing https://thesocialroi.com/story11311953/retatrutide-emerging-research-and-potential-therapeutic-uses